Efficacy of second-line treatment and prognostic factors in patients with advanced malignant peritoneal mesothelioma: a retrospective study

BACKGROUND: Standard treatment for malignant peritoneal mesothelioma has not been established, and systemic chemotherapy is administered according to malignant pleural mesothelioma. We previously reported the efficacy of cisplatin plus pemetrexed as first-line chemotherapy; however, the efficacy of...

Descripción completa

Detalles Bibliográficos
Autores principales: Kitadai, Rui, Shimoi, Tatsunori, Sudo, Kazuki, Noguchi, Emi, Nagata, Yusuke, Sawada, Ryoichi, Takashima, Atsuo, Boku, Narikazu, Yonemori, Kan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7980334/
https://www.ncbi.nlm.nih.gov/pubmed/33743636
http://dx.doi.org/10.1186/s12885-021-08025-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7980334/
https://www.ncbi.nlm.nih.gov/pubmed/33743636
http://dx.doi.org/10.1186/s12885-021-08025-x

Ejemplares similares